This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
, No Gclids
Disease Info Card
Lafora Disease
Information about Lafora Disease: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.
Overview of Lafora Disease
Most recent studies have shown that Lafora Disease shares some biological mechanisms with ataxia, atrophy, dementia, epilepsies-myoclonic, epilepsy, glycogen-storage-disease, glycogen-storage-disease-type-iv, impaired-cognition, merrf-syndrome, myoclonic-epilepsies-progressive, myoclonus, nerve-degeneration, nervous-system-disorder, nervousness, neurodegenerative-disorders, neuronal-ceroid-lipofuscinoses, tonic-clonic-epilepsy, type-i-mucolipidosis, unverricht-lundborg-syndrome.
Among the many pathways, these few ones have gauged particular interests from scientists studying Lafora Disease, and have been seen in publications frequently: Aging, Autophagy, Cell Death, Cellular Process, Dna Repair, Glucose Homeostasis, Glucose Metabolic Process, Habituation, Hyperphosphorylation, Localization, Macroautophagy, Metabolic Process, Neuron Death, Pathogenesis, Protein Phosphorylation, Protein Targeting, Reflex, Response To Endoplasmic Reticulum Stress, Translation, Transport
Quite a number of genes have been found to play important roles in Lafora Disease, such as CSTB, EPM2A, EPM2AIP1, FMN1, FOXC2, GAA, GBE1, HSPA5, INS, MUL1, NHLRC1, PPA1, PPP1R3B, PPP1R3C, TRIM50. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.
In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.